This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments
This trial was a randomized, double-blind, placebo-controlled, multinational clinical trial conducted to evaluate the efficacy and safety of 2.4 mg of semaglutide once a week in adults with obesity or overweight
Always consult your doctor before starting any new medication or changing your treatment plan
When to Consider Discontinuation : If palpitations persist despite conservative measures, are associated with documented arrhythmias on monitoring, or significantly impair quality of life, discontinuation of semaglutide may be necessary
A 10mg/ml vial contains 2.5mg in those 25 units
The GLP-1 and GIP components enhance insulin secretion and sensitivity, while the glucagon component, somewhat paradoxically, does not worsen blood sugar control because its glucose-raising effects are offset by the dominant insulin-enhancing effects of the other two pathways